HUS-Yhtymä, Helsingin yliopistollinen sairaala (HUS) - Syöpäkeskus

Helsinki, Uusimaa 00029

2 studies enrolling now · 3 studies all time

What they study most

Advanced Metastatic Castration-resistant Prostate Cancer, Advanced/Metastatic Colorectal Adenocarcinoma, Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression

Studies at this site

• First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation — Recruiting now
• A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) — Running, not enrolling